Aliaxin SV 1,1ml

120,00 2 Syringes

Aliaxin SV (Superior Volume) is the newest product in the Aliaxin range and is a non-invasive treatment designed for restoring facial volume,.
77 Items sold in last 3 months
Quantity Price Discount
1-5 120,00  2 Syringes 0%
6-10 116,40  2 Syringes 3%
11-20 114,00  2 Syringes 5%
21-30 111,60  2 Syringes 7%
31+ 108,00  2 Syringes 10%

In stock

7 People watching this product now!
Estimated delivery dates: 11/07/2025 – 22/07/2025

The dates refer to delivery to DHL Courier by DirectDermalFillers.com

SKU: DDF0174 Categories: , Brand:
Description
Aliaxin SV is the newest addition to the Aliaxin range and offers a non-invasive treatment designed to restore facial volume, enhance natural contours, and provide hydration. This product has optimal lifting capacity, making it ideal for contouring cheeks and creating sharp jawlines. Additionally, it effectively fills deep lines and wrinkles.

The cross-linked hyaluronic acid dermal filler integrates seamlessly into the skin while stimulating collagen production and restoring hydration.

Pack Contents

  • 2 x 1.1ml Syringes
  • 4 x 27G x 13mm / 27G x 19mm Needles

Benefits of Aliaxin SV

  • Restores Facial Volume: Effectively replenishes lost volume.
  • Shapes Facial Contours: Enhances the natural outline of the face.
  • Integrates Seamlessly: Blends well with the skin for a natural look.

Origin

This product comes from the European Community (EC).

Additional information
Manufacturer

Brand

Aliaxin is a dermal filler range containing a combination of different well-defined molecular weights of ultra-pure, non-animal hyaluronic acid. The complete product range contains six non-invasive and innovative treatments with specific and different viscoelastic properties. These properties make the fillers useful for natural contouring, lifting, and hydration in the different areas of the face. Key features of Aliaxin are high tissue integration and stability, resulting in natural, but at the same time long-lasting results that last up to 6 to 12 months. The Aliaxin cross-linking process results in a ready-to-use gel without the need for additional fragmentation or manipulation. All of which makes the final product safer and easier to inject thanks to the optimization of the viscoelastic characteristics.
Country of Origin